SP LABORATORIES

SP SUSTANON

€36.84

INDICATION:

In men, Sustanon is used to treat androgenic deficiency after castration, eunuchoidism, hypopituitarism, hormonal impotence, male climatic symptoms (decreased libido and physical and intellectual activity), some forms of infertility with impaired spermatogenesis, osteoporosis caused by osteoporosis and. In women, Sustanon is used to treat high levels of estrogen, uterine fibroids; endometriosis; breast cancer; osteoporosis.

CONTRAINDICATIONS:

Sustanon is not indicated for use in individual hypersensitivity to drug carcinoma, prostate and breast; hypertension hypertension, along with symptoms of urinary disorders; nephrosis or nephrotic phase of nephritis, edema; hypercalcemia; liver function disorders; Diabetes; heart or coronary insufficiency, myocardial infarction, atherosclerosis in elderly men; pregnancy, lactation.

ADMINISTRATION:

Sustanon is given by deep intramuscular injection. The dose is determined individually, depending on the patient's indication and response.

Typically, adults are given 1 ml intramuscularly once every 14 days; when a therapeutic effect is obtained, Sustanon is administered 1 ml intramuscularly once every 28 days. The duration of treatment is determined individually.

In male sterility (azoospermia, oligospermia) 2 ml 1 time in 2 weeks (in case of a painful erection, treatment is discontinued).

In the case of breast cancer in women: 1-2 ml every 1-2 weeks during the treatment period.

The drug is not administered intravenously!

MEDICAL ACTION:

Sustanon is composed of three testosterone esters (propionate, phenylpropionate, isocaproate and decanoate).

Testosterone is the main androgen hormone synthesized and released by the testicles. It is responsible for the growth and development of male sexual organs and secondary sexual characteristics (maturation of the prostate, seminal vesicles, penis and scrotum), the distribution of male hair (face, thickening, chest) develops laryngeal muscles and the distribution of body fat. It retains nitrogen, sodium, potassium and phosphorus, increases anabolism and decreases protein catabolism. Premature increase in serum testosterone in the prepubertal period causes accelerated growth and epiphyseal closure. Stimulates the production of red blood cells and erythropoietin. The feedback mechanism inhibits the pituitary secretion of luteinizing hormone and follicle and causes the suppression of spermatogenesis.

In women, Sustanon inhibits pituitary gonadotrophic function, ovarian function, mammary glands, endometrial atrophy. Due to the antagonistic action of estrogen, it is useful in the treatment of uterine fibroids, endometriosis, breast cancer. Manifested beneficial effects in the climacteric period.

PRECAUTIONS:

In case of androgen-dependent side effects, it is necessary to stop the preparation. After the disappearance of the side effects, repeat the treatment with lower doses.

Patients with latent or apparent heart failure, impaired renal function, hypertension, epilepsy or migraines (or a history of these conditions) will be under constant supervision as androgens may cause sodium retention and, in some cases, water retention. Liver function should be monitored during long-term treatment. In patients with breast cancer, hyperfamy, lung cancer, bone metastases, calcium levels should be monitored in the blood and urine. In prepubertal adolescents, this medicine should be used with caution to avoid stopping growth and premature puberty.

SIDE EFFECTS:

• Priapism and other symptoms of sexual hyperstimulation (frequent erection);

• adolescents in prepubertal age - accelerating sexual development; increased frequency of erections, increase in the number of sexual organs, closure of the premature epiphysis;

• spermatogenesis disorders and sperm maturation disorders, oligospermia and reduced ejaculation volume;

• prostate abnormalities;

• women - bleeding from the genital tract, increased libido; Prolonged administration of virilization symptoms is possible;

• hirsutism, gynecomastia;

• seborrhea, acne, oily skin, hair loss;

• water and sodium retention, edema;

• symptoms of hypercalcemia;

• thrombophlebitis;

• Nausea, cholestatic jaundice, increased liver transaminases (normalized upon discontinuation of treatment);

• headache, depression, aggression, anxiety, sleep disturbances, paresthesias, possible pain, itching and redness at the injection site.

OVERDOSE:

Seek medical help if an overdose has occurred.

Product Details